Preview

City Healthcare

Advanced search

Comorbidity of Internal Diseases as a Public Health Challenge

https://doi.org/10.47619/2713-2617.zm.2025.v.6i4-1;141-150

Abstract

Comorbidity, that is, the simultaneous presence of two or more chronic diseases, has become a prevalent phenomenon in modern medicine, especially in relation to internal pathologies. The aim of this article was to justify the need for transition from fragmented care to a personalized, multidisciplinary, and digital model for comorbidity patients, as well as to propose a “Digital Integrated Clinical Platform” concept for primary healthcare adapted to Russian background. Materials and methods. The analysis included data about 18,740 patients aged 50 years and older with multimorbidity in Moscow, the Republic of North Ossetia-Alania, and the Chechen Republic for the period 2020-2024 obtained from the Unified State Health Information System (EGISZ), electronic medical records, and regional registries. Official reporting forms of the Ministry of Health, clinical data, and the results of international studies (Chronic Care Model, ESSE-RF, HAPIEE) were used. In this study, such methods as descriptive and comparative statistics, polypharmacy analysis (STOPP/ START criteria), regression analysis predicting hospitalization length and quality of life (EQ-5D-5L), as well as system and SWOT analysis of digital platforms and care models were used. Results. Analysis of data about 18,740 patients with comorbidity revealed a high polypharmacy burden (an average of 7.3 medications), particularly in regions with low digital engagement that lack specialized care. The data confirm the need to create a unified digital platform for standardized and secure management of multimorbid patients across the country.

About the Authors

Z. S. Dzhikaeva
North Ossetian State Medical Academy
Russian Federation

Zarina S. Dzhikaeva – Cand. Sci. in Medicine, Associate Professor of the Department of Internal Diseases.

40, Pushkinskaya ul., 362019, Vladikavkaz



L. A. Kulova
North Ossetian State Medical Academy
Russian Federation

Laura A. Kulova – Cand. Sci. in Medicine, Associate Professor of the Department of Internal Diseases.

40, Pushkinskaya ul., 362019, Vladikavkaz



G. A. Arsakhanova
Kadyrov Chechen State University
Russian Federation

Gayna A. Arsakhanova – Cand. Sci. in Medicine, Associate Professor, Kadyrov Chechen State University.

32, Sheripova ul., 364024, Grozny



References

1. Barbarash O.L., Voyevoda M.I., Galstyan G.R. et al. Pre-diabetes as an Interdisciplinary Problem: Definition, Risks, Approaches to the Diagnostics and Prevention of Type 2 Diabetes and Cardiovascular Complications. Russian Journal of Cardiology. 2019;(4):83-91. https://doi.org/10.15829/1560-4071-2019-4-83-91 (In Russ.)

2. Volkova L.Yu., Eliashevich S.O., Shepel R.N. et al. A Structured Approach to dietary Modification in Adult Obese Patients in Primary Care. Preventive Medicine. 2023;26(2):94-99. https://doi.org/10.17116/profmed20232602194 (In Russ.)

3. Eliashevich S.O., Dadaeva V.A., Drapkina O.M. Losing and «Maintaining» Body Weight is a Well-Known Inequity in the Prevention of Chronic Noncommunicable Diseases. Russian Journal of Preventive Medicine. 2022;25(3):85-91. https://doi.org/10.17116/profmed20222503185 (In Russ.)

4. Shestakova M.V., Drapkina O.M., Bakulin I.G. et al. Diagnostics, Treatment, and Follow-up Observation of Patients with Prediabetes in Primary Care Settings. Guidelines. National Medical Research Center for Therapeutic and Preventive Medicine of the Ministry of Health of the Russian Federation 2021. 40

5. p. https://org.gnicpm.ru/wp-content/uploads/2021/07/diagnostika-lechenie-i-dispansernoe-nablyudenie-paczientov-s-prediabetom-v-usloviyah-msp.pdf (In Russ.)

6. Oganov R.G., Simanenkov V.I., Bakulin I.G. et al. Comorbidities in Clinical Practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019;18(1):5-66. https://doi.org/10.15829/17288800-2019-1-5-66 (In Russ.)

7. Loukianov M.M., Andreenko E.Yu., Martsevich S.Yu. et al. Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries). Rational Pharmacotherapy in Cardiology. 2020;16(6):888-898. https://doi.org/10.20996/1819-6446-2020-12-01 (In Russ.)

8. Pereverzeva K.G., Lukyanov M.M., Andreenko E.Yu. et al. Outpatient Register of Patients Who Have Suffered a Myocardial Infarction (REGATA): Prospective Follow-up Data and Outcomes. Kardiologiia. 2022;62(2):12-19. https://doi.org/10.18087/cardio.2022.2.n1712 (In Russ.)

9. Drapkina O.M., Kontsevaya A.V., Mukaneeva D.K. et al. Forecast of the Socioeconomic Burden of COPD in the Russian Federation in 2022. Pulmonologiya. 2022;32(4):507-516. https://doi.org/10.18093/0869-01892022-32-4-507-516 (In Russ.)

10. Drapkina O.M., Kontsevaya A.V., Kalinina A.M. et al. Prevention of Chronic Non-communicable Diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235. https://doi.org/10.15829/1728-8800-2022-3235 (In Russ.)


Review

For citations:


Dzhikaeva Z.S., Kulova L.A., Arsakhanova G.A. Comorbidity of Internal Diseases as a Public Health Challenge. City Healthcare. 2025;6(4-1):141-150. (In Russ.) https://doi.org/10.47619/2713-2617.zm.2025.v.6i4-1;141-150

Views: 31


ISSN 2713-2617 (Online)